BPM Capital Backs Medical Mazella
BPM Capital Backs Management Buy-In of Medical Mazella to Accelerate Growth in Rigid Packaging
Estonia-based BPM Capital has announced the financing of a management buy-in (MBI) for Medical Mazella, a Polish manufacturer specializing in rigid polymer packaging. The investment marks another transaction under BPM Mezzanine Fund II and is aimed at scaling Medical Mazella’s footprint across the pharmaceutical and laboratory packaging sectors.
The buy-in was led by Dr. Jakub Niestrój, who will also assume the role of CEO. Known for his experience in manufacturing and scale-up strategies, Dr. Niestrój plans to drive both product innovation and market expansion, with a particular focus on consolidating the fragmented packaging sector in Central and Eastern Europe.
Subscribe to Startup Digest to stay ahead with the latest news, investments, and must-attend events.
A Strategic Sector with Global Demand
Medical Mazella manufactures packaging components using materials such as PP, PET, and PE, and serves industries that require stringent safety and quality standards—including pharmaceuticals, laboratories, and e-fluids. Their facility features high-end equipment such as Battenfeld injection moulding machines and General Plastics extruders, enabling precise and efficient production.
“The buy-out of Medical Mazella is the first step in implementing an expansion strategy in the specialist packaging sector,” said Dr. Niestrój. “We’re excited to build on the company’s strong foundation and expand its client base and product offerings.”
BPM’s Role in Empowering SMEs
Founded in 2014, BPM Capital is one of the few independent mezzanine investors in the Baltics and Poland, managing close to €130 million. It is backed by heavyweight institutions including the European Investment Fund and the European Bank for Reconstruction and Development (EBRD).
The Medical Mazella deal aligns with BPM’s long-standing focus on financing small and medium-sized enterprises with strong growth potential. Its mezzanine financing structure provides flexibility for management teams to execute strategic transformations without giving up equity control too early in their growth cycle.
An Industry Primed for Consolidation
As demand for safe, sustainable, and traceable packaging solutions continues to grow—especially in the wake of tightening EU regulations—companies like Medical Mazella are well-positioned to lead the charge. With this MBI, the new management team aims to capitalize on market fragmentation by consolidating specialized players, expanding internationally, and improving operational efficiency.
This move not only signals a growth phase for Medical Mazella but also reinforces BPM Capital’s commitment to strengthening the industrial and manufacturing backbone of Central and Eastern Europe.
